MDRX — Veradigm Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid Cap

Annual income statement for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2018 December 31st	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,618	1,633	1,503	1,503	588
Cost of Revenue
Gross Profit	621	610	566	620	308
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,629	1,733	1,635	1,417	623
Operating Profit	-11.6	-100	-132	85.6	-34.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-62.2	-282	-149	162	-63.9
Provision for Income Taxes
Net Income After Taxes	-43.2	-241	-133	134	-20
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	364	-182	700	134	-86.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	364	-182	700	134	-86.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.534	-1.3	-0.52	0.987	-0.088